Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Derman

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Paediatrics and International Child Health|October 27, 2024
Antibiotic use in infants in the 6 weeks after delivery in seven low- and middle-income countries: findings from the A-PLUS trialHaleema Yasmin, Saba Tanveer, Shiyam Sunder Tikmani, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 2, 2026
Timing of Prophylactic Intrapartum Azithromycin Administration and Efficacy in Prevention of Maternal and Infant Infections: A Secondary Analysis of a Randomized Controlled TrialRupsa C Boelig, Avinash Kavi, Janet L Moore, et al.
The Lancet. Global Health|February 16, 2023
Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health ResearchJackie K Patterson, Simon Neuwahl, Norman Goco, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 19, 2026
Does Adherence Modify Low-Dose Aspirin Effects in Pregnancy? Post Hoc Analysis From a Multi-Centre TrialMusaku Mwenechanya, Abigail Mwapule Tembo, Elwyn Chomba, et al.
Lancet (London, England)|January 27, 2020
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trialMatthew K Hoffman, Shivaprasad S Goudar, Bhalachandra S Kodkany, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 12, 2026
Non-study post-partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A-PLUS randomized controlled trialElizabeth M McClure, Alan T N Tita, Waldemar A Carlo, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 12, 2022
COVID-19 antibody positivity over time and pregnancy outcomes in seven low-and-middle-income countries: A prospective, observational study of the Global Network for Women's and Children's Health ResearchRobert L Goldenberg, Sarah Saleem, Sk Masum Billah, et al.
The Lancet. Global Health|March 28, 2025
Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trialWaldemar A Carlo, Alan T N Tita, Janet L Moore, et al.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
Lancet (London, England)|December 3, 2014
A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trialFernando Althabe, José M Belizán, Elizabeth M McClure, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Paediatrics and International Child Health|October 27, 2024
Antibiotic use in infants in the 6 weeks after delivery in seven low- and middle-income countries: findings from the A-PLUS trialHaleema Yasmin, Saba Tanveer, Shiyam Sunder Tikmani, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 2, 2026
Timing of Prophylactic Intrapartum Azithromycin Administration and Efficacy in Prevention of Maternal and Infant Infections: A Secondary Analysis of a Randomized Controlled TrialRupsa C Boelig, Avinash Kavi, Janet L Moore, et al.
The Lancet. Global Health|February 16, 2023
Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health ResearchJackie K Patterson, Simon Neuwahl, Norman Goco, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 19, 2026
Does Adherence Modify Low-Dose Aspirin Effects in Pregnancy? Post Hoc Analysis From a Multi-Centre TrialMusaku Mwenechanya, Abigail Mwapule Tembo, Elwyn Chomba, et al.
Lancet (London, England)|January 27, 2020
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trialMatthew K Hoffman, Shivaprasad S Goudar, Bhalachandra S Kodkany, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 12, 2026
Non-study post-partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A-PLUS randomized controlled trialElizabeth M McClure, Alan T N Tita, Waldemar A Carlo, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 12, 2022
COVID-19 antibody positivity over time and pregnancy outcomes in seven low-and-middle-income countries: A prospective, observational study of the Global Network for Women's and Children's Health ResearchRobert L Goldenberg, Sarah Saleem, Sk Masum Billah, et al.
The Lancet. Global Health|March 28, 2025
Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trialWaldemar A Carlo, Alan T N Tita, Janet L Moore, et al.
The Lancet. Global Health|March 28, 2025
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trialJackie K Patterson, Simon Neuwahl, Sydney Kirsch, et al.
Lancet (London, England)|December 3, 2014
A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trialFernando Althabe, José M Belizán, Elizabeth M McClure, et al.
Pageof 14